Similar Familial Underpinnings for Full and Subsyndromal Pediatric Bipolar Disorder: A Familial Risk Analysis
Overview
Authors
Affiliations
Objectives: To examine the validity of subthreshold pediatric bipolar I disorder (BP-I), we compared the familial risk for BP-I in the child probands who had either full BP-I, subthreshold BP-I, ADHD, or were controls that neither had ADHD nor bipolar disorder.
Methods: BP-I probands were youth aged 6-17 years meeting criteria for BP-I, full (N=239) or subthreshold (N=43), and also included were their first-degree relatives (N=687 and N=120, respectively). Comparators were youth with ADHD (N=162), controls without ADHD or bipolar disorder (N=136), and their first-degree relatives (N=511 and N=411, respectively). We randomly selected 162 non-bipolar ADHD probands and 136 non-bipolar, non-ADHD control probands of similar age and sex distribution to the BP-I probands from our case-control ADHD family studies. Psychiatric assessments were made by trained psychometricians using the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children Epidemiological Version (KSADS-E) and Structured Clinical Interview for DSM-IV (SCID) structured diagnostic interviews. We analyzed rates of bipolar disorder using multinomial logistic regression.
Results: Rates of full BP-I significantly differed between the four groups (χ =32.72, P<.001): relatives of full BP-I probands and relatives of subthreshold BP-I probands had significantly higher rates of full BP-I than relatives of ADHD probands and relatives of control probands. Relatives of full BP-I, subthreshold BP-I, and ADHD probands also had significantly higher rates of major depressive disorder compared to relatives of control probands.
Conclusions: Our results showed that youth with subthreshold BP-I had similarly elevated risk for BP-I and major depressive disorder in first-degree relatives as youth with full BP-I. These findings support the diagnostic continuity between subsyndromal and fully syndromatic states of pediatric BP-I disorder.
Pediatric Bipolar Disorder: Challenges in Diagnosis and Treatment.
Wozniak J, OConnor H, Iorini M, Ambrose A Paediatr Drugs. 2024; 27(2):125-142.
PMID: 39592559 PMC: 11829910. DOI: 10.1007/s40272-024-00669-z.
Wozniak J, DiSalvo M, Farrell A, Joshi G, Uchida M, Faraone S J Psychiatr Res. 2022; 151:667-675.
PMID: 35667335 PMC: 10043808. DOI: 10.1016/j.jpsychires.2022.04.008.
Wozniak J, DiSalvo M, Farrell A, Vaudreuil C, Uchida M, Ceranoglu T BMC Psychiatry. 2022; 22(1):314.
PMID: 35505312 PMC: 9066881. DOI: 10.1186/s12888-022-03943-x.
Wozniak J, Wolenski R, Fitzgerald M, Faraone S, Joshi G, Uchida M Scand J Child Adolesc Psychiatr Psychol. 2021; 6(1):40-51.
PMID: 33520750 PMC: 7750699. DOI: 10.21307/sjcapp-2018-005.
Toward prevention of bipolar disorder in at-risk children: Potential strategies ahead of the data.
Post R, Goldstein B, Birmaher B, Findling R, Frey B, DelBello M J Affect Disord. 2020; 272:508-520.
PMID: 32553395 PMC: 8986089. DOI: 10.1016/j.jad.2020.03.025.